These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2413663)

  • 41. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bacterial Opsonization Changes Adhesion Interactions between Endothelial Cells and Neutrophils in a Model of Experimental Septicemia.
    Pleskova SN; Bobyk SZ; Bezrukov NA; Lazarenko EV
    Bull Exp Biol Med; 2024 Jun; 177(2):243-247. PubMed ID: 39090462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A role for IgM in the in vitro opsonisation of Staphylococcus aureus and Escherichia coli by bovine polymorphonuclear leucocytes.
    Williams MR; Hill AW
    Res Vet Sci; 1982 Jul; 33(1):47-53. PubMed ID: 6753075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibacterial mechanisms of antibody to mannose-sensitive pili of Escherichia coli.
    Weinstein R; Silverblatt FJ
    J Infect Dis; 1983 May; 147(5):882-9. PubMed ID: 6132951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes.
    Hoidal JR; Schmeling D; Peterson PK
    J Infect Dis; 1981 Jul; 144(1):61-71. PubMed ID: 7021701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Quantitative characteristics of human antibodies to the peptidoglycans of different Staphylococcus species].
    Astaf'ev DG; Maianskiĭ AN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):55-7. PubMed ID: 3296579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological characteristics of peptidoglycans of group A streptococcus and some other bacterial species. II. Immunological mechanisms involved in thrombocytolysis.
    Rýc M; Rotta J
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(4):435-41. PubMed ID: 38280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of opsonins in clinical response to granulocyte transfusion in granulocytopenic patients.
    Keusch GT; Ambinder EP; Kovacs I; Goldberg JD; Phillips DM; Holland JF
    Am J Med; 1982 Oct; 73(4):552-63. PubMed ID: 6751084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uterine secretions induce phagocytosis of Escherichia coli by neutrophils.
    Matsuda H; Sasai H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):474-82. PubMed ID: 3541457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of human neutrophil type 3 complement receptor (iC3b receptor) expression during phagocytosis of Staphylococcus aureus and Escherichia coli.
    Gordon DL; Rice JL; McDonald PJ
    Immunology; 1989 Aug; 67(4):460-5. PubMed ID: 2527804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
    Vreede RW; Leuvenink J; Bouter AS; Brouwer EC; Marcelis JH; Verhoef J
    Eur J Clin Microbiol; 1986 Apr; 5(2):141-7. PubMed ID: 3522225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The response of human lymphocytes to Staphylococcus aureus peptidoglycan in a system of opsonic cooperation].
    Maianskiĭ AN; Osipov OA; Astaf'ev DG
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Dec; (12):46-8. PubMed ID: 1789035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy.
    Yang KD; Bathras JM; Shigeoka AO; James J; Pincus SH; Hill HR
    J Infect Dis; 1989 Apr; 159(4):701-7. PubMed ID: 2494269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay.
    Hiemstra PS; Brands-Tajouiti J; van Furth R
    J Lab Clin Med; 1994 Feb; 123(2):241-6. PubMed ID: 8301200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Roles of antibody and complement in the bactericidal activity of mouse peritoneal exudate neutrophils.
    Hart PH; Spencer LK; Hill NL; McDonald PJ; Finlay-Jones JJ
    Br J Exp Pathol; 1987 Feb; 68(1):89-100. PubMed ID: 3545276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus.
    Rozalska B; Wadström T
    Scand J Immunol; 1993 May; 37(5):575-80. PubMed ID: 8484103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction of mycoplasmas and phagocytes.
    Howard CJ; Taylor G
    Yale J Biol Med; 1983; 56(5-6):643-8. PubMed ID: 6236619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Requirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilli.
    Leist-Welsh P; Bjornson AB
    Infect Immun; 1979 Oct; 26(1):99-109. PubMed ID: 387613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.